Interaction of organophosphate pesticides and related compounds with the androgen receptor

Environmental Health Perspectives

Volumn 111, Issue 4, 2003, Pages 545-552

  Tamura, Hiroto ^a   Yoshikawa, Hiromichi ^b   Gaido, Kevin W ^c   Ross, Susan M ^c   DeLisle, Robert K ^d   Welsh, William J ^e   Richard, Ann M ^f  

^a MEIJO UNIVERSITY   (Japan)

^b KYUSHU KYORITSU UNIVERSITY   (Japan)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^d Accelrys   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Androgen receptor; Fenitrothion; HepG2 cells; Homology model; Organophosphates; Structure activity relationships

Indexed keywords

ALKYL GROUP; ANDROGEN RECEPTOR; ANTIANDROGEN; ENVIRONMENTAL CHEMICAL; FENITROTHION; FLUTAMIDE; HORMONE ANTAGONIST; HYDROXYFLUTAMIDE; LINURON; LUCIFERASE; ORGANOPHOSPHATE PESTICIDE; PARATHION; PARATHION METHYL; PHENYL GROUP;

CELL STRAIN HEPG2; CHEMICAL INTERACTION; CONTROLLED STUDY; CRYSTALLOGRAPHY; ELECTRON; ENERGY; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROLYSIS; HYPOTHESIS; MOLECULAR MODEL; MOUSE MAMMARY TUMOR ONCOVIRUS; PRIORITY JOURNAL; RECEPTOR BINDING; REPORTER GENE; REVIEW; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION;

MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE;

EID: 0038408658     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.5671     Document Type: Review

References (49)

1. Anstead GM, Carlson KE, Katzenellenbogen JA. 1997. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62:268-303.
2. Buchanan G, Yang M, Harris HM, Nahm HS, Han G, Moore N, et al. 2001. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Mol Endocrin 15:46-56.
3. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
4. Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, et al. 1997. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36:1052-1064.
5. Eto M, ed. 1974. Organophosphorus Pesticides: Organic and Biological Chemistry. New York:CRC Press.
6. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, et al. 2001. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14:280-294.
7. Goldstein RA, Katzenellenbogen JA, Luthey-Schulten ZA, Seielstad DA, Wolynes PG. 1993. Three-dimensional model for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 90:9949-9953.
8. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. 1998. The androgen receptor gene mutations data base. Nucleic Acids Res 26:234-238.
9. Gray LE Jr, Ostby J, Cooper RL, Kelce WR. 1999a. The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol Ind Health 15:37-47.
10. Gray LE Jr, Ostby J, Monosson E, Kelce WR. 1999b. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health 15:48-64.
11. Gray LE Jr, Wolf C, Lambright C, Mann P, Price M, Cooper RL, et al. 1999c. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 15:94-118.
12. Ing NH, O'Malley BW. 1995. The steroid hormone receptor superfamily-molecular mechanisms of action. In: Molecular Endoclinology: Basic Concepts and Clinical Correlations (Weintraub B, ed). New York:Raven Press, 195-215.
13. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr. 1994. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126:276-285.
14. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. 1995. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375:581-585.
15. Kenakin T. 1993. Competitive antagonism. In: Pharmacologic Analysis of Drug-Receptor Interaction (Kenakin T, ed). New York:Raven Press, 279-322.
16. Loughney DA, Schwender CF. 1992. A comparison of progestin and androgen receptor binding using the CoMFA technique. J Comput Aided Mol Des 6:569-581.
17. Maness SC, McDonnell DP, Gaido KW. 1998. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Toxicol Appl Pharmacol 151:135-142.
18. Marhefka CA, Moore BM, Bishop TC, Kirkovsky L, Mukherjee A, Dalton J, et al. 2001. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. J Med Chem 44:1729-1740.
19. ccr) derived from an androgen-independent prostate cancer. J Med Chem 45:1439-1446.
20. Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, et al. 2000. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275:26164-26171.
21. McIntyre BS, Barlow NJ, Wallace DG, Maness SC, Gaido KW, Foster PMD. 2000. Effects of in utero exposure to linuron on androgen-dependent reproductive development in the male Crl:CD(SD)BR rat. Toxicol Appl Pharmacol 167:87-99.
22. McKinney JD, Waller CL. 1994. Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect 102:290-297.
23. Mekenyan OG, Ivanov JM, Karabunarliev SH, Bradbury SP, Ankley GT, Karcher W. 1997. COREPA: A new approach for the elucidation of Common Reactivity Patterns of chemicals. I. Stereoelectronic requirements for androgen receptor binding. Environ Sci Technol 31:3702-3711.
24. Monosson E, Kelce WR, Lambright C, Ostby J, Gray LE Jr. 1999. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol Ind Health 15:65-79.
25. Nishizawa Y, Nakagawa M, Suzuki H, Sakamoto H, Mizutani T. 1961. Studies on the organophosphorus insecticides. VI. Development of new low toxic phosphorus insecticides. Agricul Biol Chem 25:597-610.
26. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE Jr. 1999. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 15:80-93.
27. Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, et al. 1999. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618.
28. Poujol N, Wurtz JM, Tahiri B, Lumbroso S, Nicolas JC, Moras D, et al. 2000. Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem 275:24022-24031.
29. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, et al. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid, Nature 378:681-689.
30. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, et al. 2001. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909.
31. Safe SH, Zacharewski T. 1997. Organochlorine exposure and risk for breast cancer. Prog Clin Biol Res 396:133-145.
32. Singh MS, Gauthier S, Labrie F. 2000. Androgen receptor antagonists (antiandrogens): structure activity relationships. Curr Med Chem 7:211-247.
33. Stewart JJP. 1998. Optimization of parameters for semiempirical methods. I. Method. J Comp Chem 10:209-220.
34. Sultan C, Lumbroso S, Poujol N, Belon C, Boudon C, Lobaccaro JM. 1993. Mutations of androgen receptor gene in androgen insensitivity syndromes. J Steroid Biochem Mol Biol 46:519-530.
35. Tamura H, Maness SC, Reischmann KP, Dorman D, Gray LE Jr, Gaido KW. 2001. Fenitrothion: androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicol Sci 60:56-62.
36. Tanenbaum DM, Wang Y, Williams SP, Sigler PB. 1998. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95:5998-6003.
37. Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, et al. 1999. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 59:2511-2515.
38. Teutsch G, Goubet F, Battmann T, Bonfils A, Bouchoux F, Cerede E, 1994. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. J Steroid Biochem Mol Biol 48:111-119.
39. Tong W, Perkins R, Strelitz R, Collantes ER, Keenan S, Welsh WJ, et al. 1997a. Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. Environ Health Perspect 105:1116-1124.
40. Tong W, Perkins R, Xing L, Welsh WJ, Sheehan DM. 1997b. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrinology 138:4022-4025.
41. Tong W, Lowis DR, Perkins R, Chen Y, Welsh WJ, Goddette DW, et al. 1998. Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J Chem Inf Comput Sci 38:669-677.
42. Tucker H, Crook JW, Chesterson GJ. 1988. Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. J Med Chem 31:954-959.
43. Waller CL, Juma BW, Gray LE Jr, Kelce WR. 1996a. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol 137:219-227.
44. Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, et al. 1996b. Ligand-based identification of environmental estrogens. Chem Res Toxicol 9:1240-1248.
45. Wiese TE, Brooks SC. 1994. Molecular modeling of steroidal estrogens: novel conformations and their role in biological activity. J Steroid Biochem Mol Biol 50:61-73.
46. Wolff MS, Toniolo PG. 1995. Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ Health Perspect 103(suppl 7):141-145.
47. Wong C, Kelce WR, Sar M, Wilson EM. 1995. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem 270:19998-20003.
48. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, et al. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:206.
49. Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, et al. 1990. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534-540.